Ticker Scorecard - VRNA Basics Company: Verona Pharma IPO Date: April 24, 2017 Sector: Healthcare Industry: Biotech Market Cap: $5.56B Activated in VL: True Average Daily Range Avg Daily Range: $0.34 | 2.86% Avg Daily Range (30 D): $1.57 | 2.90% Avg Daily Range (90 D): $1.15 | 2.57% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): 1.42M Avg Daily Volume (90 D): 1.07M Trade Size Avg Trade Size (Sh.): 106 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 1,067 Avg Inst. Trade: $1.54M Avg Inst. Trade (30 D): $1.68M Avg Inst. Trade (90 D): $1.9M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.39M Avg Closing Trade (30 D): $2.86M Avg Closing Trade (90 D): $1.87M Avg Closing Volume: 47.52K     News Feb 13, 2025 @ 11:00 AM Verona Pharma to Report Fourth Quarter and Full Ye... Source: N/A Jan 21, 2025 @ 6:00 PM Bronchiectasis Market to Show Positive Growth at a... Source: Delveinsight Jan 7, 2025 @ 11:00 AM Verona Pharma Reports Strong Ohtuvayre™ L... Source: Verona Pharma Nov 4, 2024 @ 7:00 AM Verona Pharma Reports Third Quarter 2024 Financial... Source: Verona Pharma Plc Jul 30, 2024 @ 6:00 AM Verona Pharma to Present at 44th Annual Canaccord ... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.25 $-.07 $-.11 Diluted EPS $-.25 $-.07 $-.11 Revenue $ 5.62M $ 5.62M $ M Gross Profit $ $ $ Net Income / Loss $ -153.72M $ -42.96M $ -70.84M Operating Income / Loss $ -155.38M $ -40.67M $ -68.42M Cost of Revenue $ $ $ Net Cash Flow $ 63.47M $ -68.56M $ 149.72M PE Ratio